EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

Benzer Materyaller

• Prevalence, clinicopathologic associations and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas
  Yazar:: Arcila, Maria E, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma
  Yazar:: He, Mai, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• EGFR exon 20 insertions in advanced lung adenocarcinomas: clinical outcomes and response to erlotinib
  Yazar:: Naidoo, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Response to standard therapies and comprehensive genomic analysis for patients with lung adenocarcinoma with EGFR exon 20 insertions
  Yazar:: Choudhury, Noura J., ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR mutant Lung Cancers
  Yazar:: Yu, Helena A., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)